Xenon Pharmaceuticals (NASDAQ:XENE) Upgraded at StockNews.com
StockNews.com upgraded shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a sell rating to a hold rating in a research note released on Thursday morning. Other analysts have also issued reports about the company. Deutsche Bank Aktiengesellschaft started coverage on Xenon Pharmaceuticals in a report on Tuesday, February 11th. They issued a “buy” rating […]
StockNews.com upgraded shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) from a sell rating to a hold rating in a research note released on Thursday morning. Other analysts have also issued reports about the company. Deutsche Bank Aktiengesellschaft started coverage on Xenon Pharmaceuticals in a report on Tuesday, February 11th. They issued a “buy” rating […]
